Drug-Eluting Bioabsorbable Stents Market

Drug-Eluting Bioabsorbable Stents Market contains market size and forecasts of Drug-Eluting Bioabsorbable Stents in global, including the following market information:
Global Drug-Eluting Bioabsorbable Stents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Drug-Eluting Bioabsorbable Stents Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Drug-Eluting Bioabsorbable Stents companies in 2021 (%)
The global Drug-Eluting Bioabsorbable Stents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serolimus and Paclitaxel Drug-Eluting Stents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug-Eluting Bioabsorbable Stents include Medtronic, B.Braun Melsungen, Abbott Laboratories, Boston Scientific Corporation, Biosensors International, Terumo Corporation., MicroPort Scientific Corporation, Alvimedica and Biotronik, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug-Eluting Bioabsorbable Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug-Eluting Bioabsorbable Stents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug-Eluting Bioabsorbable Stents Market Segment Percentages, by Type, 2021 (%)
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Global Drug-Eluting Bioabsorbable Stents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug-Eluting Bioabsorbable Stents Market Segment Percentages, by Application, 2021 (%)
Coronary Artery Diseases
Peripheral Artery Diseases
Global Drug-Eluting Bioabsorbable Stents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug-Eluting Bioabsorbable Stents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug-Eluting Bioabsorbable Stents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Drug-Eluting Bioabsorbable Stents revenues share in global market, 2021 (%)
Key companies Drug-Eluting Bioabsorbable Stents sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Drug-Eluting Bioabsorbable Stents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies